57 USD
+1.25 (+2.24%)
57 USD
0 (0%)
Overall MDLZ gets a fundamental rating of 4 out of 10. We evaluated MDLZ against 87 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are quite some concerns on its financial health. MDLZ has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
MDLZ had positive earnings in each of the past 5 years.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
MDLZ has a better Return On Assets (4.95%) than 71.26% of its industry peers.
Looking at the Return On Equity, with a value of 13.49%, MDLZ belongs to the top of the industry, outperforming 81.61% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.25%, MDLZ is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ's Profit Margin of 9.38% is amongst the best of the industry. MDLZ outperforms 86.21% of its industry peers.
MDLZ's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.59%, MDLZ is in the better half of the industry, outperforming 78.16% of the companies in the same industry.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a better Gross Margin (31.05%) than 73.56% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
MDLZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
MDLZ has an Altman-Z score of 2.26. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, MDLZ is in line with its industry, outperforming 55.17% of the companies in the same industry.
The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.31, MDLZ is doing good in the industry, outperforming 63.22% of the companies in the same industry.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
The Debt to Equity ratio of MDLZ (0.76) is worse than 63.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.84
WACC7.4%
2.3 Liquidity
A Current Ratio of 0.61 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a Current ratio of 0.61. This is amonst the worse of the industry: MDLZ underperforms 88.51% of its industry peers.
MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MDLZ (0.37) is worse than 81.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 4.13%.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.92% yearly.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MDLZ is valuated rather expensively with a Price/Earnings ratio of 20.00.
MDLZ's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.45. MDLZ is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.44 indicates a rather expensive valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
MDLZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20 | ||
| Fwd PE | 17.44 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.21 | ||
| EV/EBITDA | 15.69 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.89
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.51%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.15, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, MDLZ pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
57
+1.25 (+2.24%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners88.19%
Inst Owner Change3.08%
Ins Owners0.14%
Ins Owner Change0.85%
Market Cap73.76B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts75.88
Price Target72.78 (27.68%)
Short Float %2.09%
Short Ratio3.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-2.85%
PT rev (3m)-3.08%
EPS NQ rev (1m)-13.53%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)-3.1%
EPS NY rev (3m)-2.83%
Revenue NQ rev (1m)-0.99%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20 | ||
| Fwd PE | 17.44 | ||
| P/S | 1.96 | ||
| P/FCF | 32.21 | ||
| P/OCF | 20.63 | ||
| P/B | 2.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.69 |
EPS(TTM)2.85
EY5%
EPS(NY)3.27
Fwd EY5.73%
FCF(TTM)1.77
FCFY3.1%
OCF(TTM)2.76
OCFY4.85%
SpS29.09
BVpS20.23
TBVpS-13.67
PEG (NY)N/A
PEG (5Y)2.89
Graham Number36.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.26 |
F-Score5
WACC7.4%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20 and the Price/Book (PB) ratio is 2.82.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.